| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,133,441 | 1,056,333 | 962,932 | 1,125,382 | | Cost of Revenue | (495,945) | 787,062 | 775,094 | 909,446 | | | Gross Profit | 1,629,386 | 269,271 | 187,838 | 215,936 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,540,862 | 154,447 | 153,233 | 137,195 | | Non Recurring |
-
|
-
| 134,813 | 61,669 | | Others | 47,390 | 48,858 | 50,104 | 52,235 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 41,134 | 65,966 | (150,312) | (35,163) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (246) | 399 | 106 | 689 | | Earnings Before Interest And Taxes | 40,888 | 66,365 | (150,206) | (34,474) | | Interest Expense | 15,864 | 16,980 | 15,619 | 15,147 | | Income Before Tax | 25,024 | 49,385 | (165,825) | (49,621) | | Income Tax Expense | 11,532 | 16,346 | (13,476) | (1,642) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,492 | 33,039 | (152,349) | (47,979) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 6,717 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,492 | 33,039 | (152,349) | (41,262) | | Preferred Stock And Other Adjustments |
-
| (1,572) | (1,617) | (1,760) | | | Net Income Applicable To Common Shares | $13,492 | $31,467 | ($153,966) | ($43,022) |
|
0.16% Nasdaq 
0.76 (2.04%) 
Income Statement
